338 related articles for article (PubMed ID: 33148639)
1. Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease.
Heller GT; Aprile FA; Michaels TCT; Limbocker R; Perni M; Ruggeri FS; Mannini B; Löhr T; Bonomi M; Camilloni C; De Simone A; Felli IC; Pierattelli R; Knowles TPJ; Dobson CM; Vendruscolo M
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148639
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Targeted Aβ
Mei J; Yang H; Sun B; Liu C; Ai H
ACS Chem Neurosci; 2021 Apr; 12(7):1197-1209. PubMed ID: 33687193
[TBL] [Abstract][Full Text] [Related]
3. A Small Molecule Stabilizes the Disordered Native State of the Alzheimer's Aβ Peptide.
Löhr T; Kohlhoff K; Heller GT; Camilloni C; Vendruscolo M
ACS Chem Neurosci; 2022 Jun; 13(12):1738-1745. PubMed ID: 35649268
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.
Hoyer W; Grönwall C; Jonsson A; Ståhl S; Härd T
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5099-104. PubMed ID: 18375754
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.
Hey JA; Kocis P; Hort J; Abushakra S; Power A; Vyhnálek M; Yu JY; Tolar M
CNS Drugs; 2018 Sep; 32(9):849-861. PubMed ID: 30076539
[TBL] [Abstract][Full Text] [Related]
8. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M
Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
11. Identification of Catechins' Binding Sites in Monomeric A
Firouzi R; Sowlati-Hashjin S; Chávez-García C; Ashouri M; Karimi-Jafari MH; Karttunen M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175868
[TBL] [Abstract][Full Text] [Related]
12. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure.
Boopathi S; Poma AB; Garduño-Juárez R
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639140
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
15. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
Andarzi Gargari S; Barzegar A; Tarinejad A
PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
[TBL] [Abstract][Full Text] [Related]
16. Stabilization Mechanism for a Nonfibrillar Amyloid β Oligomer Based on Formation of a Hydrophobic Core Determined by Dissipative Particle Dynamics.
Kawai R; Chiba S; Okuwaki K; Kanada R; Doi H; Ono M; Mochizuki Y; Okuno Y
ACS Chem Neurosci; 2020 Feb; 11(3):385-394. PubMed ID: 31899612
[TBL] [Abstract][Full Text] [Related]
17. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
[TBL] [Abstract][Full Text] [Related]
18. α
Paterna A; Santonicola P; Di Prima G; Rao E; Raccosta S; Zampi G; Russo C; Moran O; Manno M; Di Schiavi E; Librizzi F; Carrotta R
ACS Chem Neurosci; 2023 Nov; 14(21):3894-3904. PubMed ID: 37847529
[TBL] [Abstract][Full Text] [Related]
19. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease.
Habchi J; Chia S; Limbocker R; Mannini B; Ahn M; Perni M; Hansson O; Arosio P; Kumita JR; Challa PK; Cohen SI; Linse S; Dobson CM; Knowles TP; Vendruscolo M
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):E200-E208. PubMed ID: 28011763
[TBL] [Abstract][Full Text] [Related]
20. Functional Gallic Acid-Based Dendrimers as Synthetic Nanotools to Remodel Amyloid-β-42 into Noncytotoxic Forms.
Araújo AR; Correa J; Dominguez-Arca V; Reis RL; Fernandez-Megia E; Pires RA
ACS Appl Mater Interfaces; 2021 Dec; 13(50):59673-59682. PubMed ID: 34874691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
